Codex DNA Inc

Change company Symbol lookup

Select an option...

DNAY Codex DNA Inc

SPCE Virgin Galactic Holdings Inc

BBLG Bone Biologics Corp

RPT RPT Realty

CLM Cornerstone Strategic Value Fund

RCI Rogers Communications Inc

ADRA Adara Acquisition Corp

EVTC Evertec Inc

OPEN Opendoor Technologies Inc

XAIR Beyond Air Inc

Go

Codex DNA, Inc. is a synthetic biology company focused on enabling researchers to build or write synthetic deoxyribonucleic acid (DNA) and messenger ribonucleic acid (mRNA). Its synthetic biology solution addresses the bottlenecks across the multi-step process of building DNA and mRNA, as well as the limitations of existing solutions that prevent the building of DNA and mRNA at a useable scale. Its BioXp system is an end-to-end automated workstation. It has developed and commercialized products, which include BioXp systems, including BioXp 3250 system, BioXp kits for generating an array of synthetic DNA and mRNA, and benchtop reagents that complement the automated synthetic biology workflow applications and workflow solutions. It has launched eight BioXp kits, three benchtop reagent kits, and various other synthetic biology products, including 14 SARS-CoV-2 full-length genomes and RNA controls, as well as its Vmax X2 cells. It has placed approximately 200 BioXp systems globally.